Clinical Trial Update: Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating sirolimus for newly diagnosed primary acquired pure red cell aplasia (PRCA) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pure Red Cell Aplasia Acquired

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Bing Han | Conditions: Pure Red Cell Aplasia, Acquired | Phase 4 | Status: COMPLETED